in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—20 June 2013
8:30 AM MDT | June 21, 2013 | Deepti Ramesh
Ash Stevens to manufacture ponatinib API Ash Stevens (Riverview, MI), a provider of global contract pharmaceutical drug substance development and active pharmaceutical ingredient (API) manufacturing services, says that the US FDA has approved Ash Stevens’ manufacturing facility at Riverview, for the manufacture of the API in Ariad Pharmaceuticals' recently approved oncology drug Iclusig -ponatinib. The drug was granted accelerated approval in December 2012 by the FDA for the treatment of adult patients with chronic, accelerated or blast phase chronic...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee